Bispecific antibodies enhancing cell mediated immune responses
US-2024174768-A1 · May 30, 2024 · US
containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K2319/033 |
| Official title | containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif |
| Display label | containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif |
| Total patents | 168 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 7 |
| 2017 | 11 |
| 2018 | 13 |
| 2019 | 22 |
| 2020 | 20 |
| 2021 | 15 |
| 2022 | 19 |
| 2023 | 20 |
| 2024 | 21 |
| 2025 | 13 |
| 2026 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Novel chimeric antigen receptors and libraries
US-2020325241-A1 · Oct 15, 2020 · US
Therapeutic spalt-like transcription factor 4 (SALL4) peptide
US-10793601-B2 · Oct 6, 2020 · US
Antigen-binding proteins targeting melanoma differentiation antigens and uses thereof
US-2019375855-A1 · Dec 12, 2019 · US
Treatment of cancer using chimeric t cell receptor proteins having multiple specificities
US-2019375815-A1 · Dec 12, 2019 · US
Calreticulin and fusion proteins
US-2019367568-A1 · Dec 5, 2019 · US
Multivalent cd20-binding molecules comprising shiga toxin a subunit effector regions and enriched compositions thereof
US-2019359657-A1 · Nov 28, 2019 · US
Constructs targeting histone h3 peptide/mhc complexes and uses thereof
US-2019338035-A1 · Nov 7, 2019 · US
Peptidic protein kinase c inhibitors and uses thereof
US-2019337982-A1 · Nov 7, 2019 · US
Chimeric Antigen Receptors Comprising BCMA-specific Fibronectin Type III Domains and Uses Thereof
US-2019330361-A1 · Oct 31, 2019 · US
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
US-2019328662-A1 · Oct 31, 2019 · US
Ciliary Neurotrophic Factor Receptor Ligands and Methods of Using the Same
US-2019328837-A1 · Oct 31, 2019 · US
Methods and compositions for use of therapeutic t cells in combination with kinase inhibitors
US-2019328786-A1 · Oct 31, 2019 · US
Humanized anti-muc1* antibodies and use of cleavage enzyme
US-2019290692-A1 · Sep 26, 2019 · US
Induced activation in dendritic cells
US-10420824-B2 · Sep 24, 2019 · US
Multivalent CD20-binding molecules comprising Shiga toxin A subunit effector regions and enriched compositions thereof
US-10392425-B2 · Aug 27, 2019 · US
Therapeutic SALL4 Peptide
US-2019218253-A1 · Jul 18, 2019 · US
Non-human animals comprising a humanized trkb locus
US-2019159436-A1 · May 30, 2019 · US
Anti-cd7 chimeric antigen receptor and method of use thereof
US-2019144522-A1 · May 16, 2019 · US
High affinity b7-h6 antibodies and antibody fragments
US-2019127470-A1 · May 2, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K2319/033?
- CPC C07K2319/033 is the Cooperative Patent Classification code for “containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif.”
- How many patents are filed under CPC C07K2319/033 (containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif)?
- Our database includes 168 publications tagged with this CPC code.
- Is patent activity under CPC C07K2319/033 growing?
- Publication counts under this code: 21 in 2024 vs 13 in 2025 (latest complete years).